FERRIC CARBOXYMALTOSE

Ferric Carboxymaltose is an intravenous iron complex used for iron replenishment in the management of iron deficiency and iron deficiency anaemia. It is formulated as a stable iron-carbohydrate complex designed to provide controlled iron release.

Ferric Carboxymaltose is used in formulations for iron deficiency anaemia associated with chronic kidney disease and end-stage renal disease, poor response to oral iron, perioperative haemoglobin optimisation, and selected gastroenterology and gynaecology applications. Other highlighted applications include heart failure, antenatal and postpartum recovery, elderly and intensive-care settings, and palliative care.

Ferric Carboxymaltose provides iron through intravenous administration and may be used where oral iron is poorly tolerated or does not provide an adequate response, allowing iron replacement without relying on gastrointestinal absorption.

Ferric Carboxymaltose is a stable iron-carbohydrate complex that enables controlled release of iron while maintaining low levels of labile iron.

Ferric Carboxymaltose offers a stable iron-carbohydrate complex with controlled iron release and supports high-dose administration, potentially requiring fewer treatment sessions compared with conventional iron sucrose therapy.